Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Rev. chil. pediatr ; 86(4): 279-282, ago. 2015. graf
Article Dans Espagnol | LILACS | ID: lil-764085

Résumé

Introducción: La rabdomiólisis es una enfermedad poco frecuente en pediatría. El objetivo es presentar un paciente en el que se desarrolló secundario a una deshidratación hipernatrémica grave tras una diarrea aguda. Caso clínico: Lactante de 11 meses que consultó por fiebre, vómitos, diarrea y anuria. Presentó convulsión tónico-clónica autolimitada. Ingresó en mal estado general, severamente deshidratado, con escasa reactividad. En las pruebas complementarias destacó acidosis metabólica grave, hipernatremia e insuficiencia renal prerrenal. Al tercer día apreció leve hipotonía axial y elevación de creatín fosfokinasa 75.076 UI/l, interpretado como rabdomiólisis. Se inició hiperhidratación y alcalinización sistémica, con buena respuesta clínica y bioquímica, siendo dado de alta sin secuelas motoras. Conclusiones: La hipernatremia grave está descrita como causa rara de rabdomiólisis e insuficiencia renal. En pacientes críticos es importante un alto índice de sospecha de rabdomiólisis y determinación seriada de la creatín fosfokinasa para su detección y tratamiento precoz.


Introduction: Rhabdomyolysis is a rare paediatric condition. The case is presented of a patient in whom this developed secondary to severe hypernatraemic dehydration following acute diarrhoea. Case report: Infant 11 months of age who presented with vomiting, fever, diarrhoea and anuria for 15 hours. Parents reported adequate preparation of artificial formula and oral rehydration solution. He was admitted with malaise, severe dehydration signs and symptoms, cyanosis, and low reactivity. The laboratory tests highlighted severe metabolic acidosis, hypernatraemia and pre-renal kidney failure (Sodium [Na] plasma 181 mEq/L, urine density> 1030). He was managed in Intensive Care Unit with gradual clinical and renal function improvement. On the third day, slight axial hypotonia and elevated cell lysis enzymes (creatine phosphokinase 75,076 IU/L) were observed, interpreted as rhabdomyolysis. He was treated with intravenous rehydration up to 1.5 times the basal requirements, and he showed a good clinical and biochemical response, being discharged 12 days after admission without motor sequelae. Conclusions: Severe hypernatraemia is described as a rare cause of rhabdomyolysis and renal failure. In critically ill patients, it is important to have a high index of suspicion for rhabdomyolysis and performing serial determinations of creatine phosphokinase for early detection and treatment.


Sujets)
Animaux , Cochons d'Inde , Lapins , Cytosine/analogues et dérivés , Préparations à action retardée/administration et posologie , Préparations à action retardée/composition chimique , Phosphonates/administration et posologie , Phosphonates/composition chimique , Corps vitré/effets des médicaments et des substances chimiques , Antiviraux/administration et posologie , Antiviraux/composition chimique , Chimie pharmaceutique/méthodes , Cytosine/administration et posologie , Cytosine/composition chimique , Systèmes de délivrance de médicaments/méthodes , Période , Herpès/traitement médicamenteux , Herpèsvirus humain de type 1/effets des médicaments et des substances chimiques , Injections intravitréennes/méthodes , Micelles , Promédicaments/administration et posologie , Promédicaments/composition chimique , Rétine/effets des médicaments et des substances chimiques , Rétine/virologie , Corps vitré/virologie
2.
Jordan Journal of Pharmaceutical Sciences. 2013; 6 (2): 223-232
Dans Anglais | IMEMR | ID: emr-143068

Résumé

This work deals with multiple response simultaneous optimization using the Derringer's desirability function for the development of a reversed phase HPLC method for the simultaneous determination of lamivudine, tenofovir and efavirenz in commercial pharmaceutical preparations. Twenty experiments, taking the capacity factor of the first peak, resolution between the second and third peaks and the retention time of the third peak as the responses with three important variables as organic phase composition, buffer molarity, and flow rate, were used to design mathematical models. The experimental responses were fitted into a second order polynomial and the three responses were simultaneously optimized to predict the optimum conditions for the effective separation of the studied compounds. The optimum assay conditions were: methanol-triethylamine buffer [pH 3.0; 15.3 mM] [35:65%v/v] as the mobile phase and at a flow rate of 1.19 ml/min. While using this optimum condition, a baseline separation with a minimum resolution of 2.0 and a run time of less than 6 min was achieved. The method showed a good agreement between the experimental data and predictive value throughout the studied parameter space. The optimized assay condition was validated according to the International Conference on Harmonization guidelines to confirm specificity, linearity, accuracy, and precision.


Sujets)
Lamivudine/composition chimique , Phosphonates/composition chimique , Benzoxazines/composition chimique , Reproductibilité des résultats , Adénine/administration et posologie , Chromatographie en phase inverse , Sensibilité et spécificité , Préparations pharmaceutiques
SÉLECTION CITATIONS
Détails de la recherche